Skip to main content

Table 1 Participants’ characteristics

From: Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country

  Total Patients seen in the ED and released Patients seen in the ED and admitted
Number of unique patients (n,%) 1144 (100%) 763 (66.7%) 381 (33.3%)
Age in years (mean; sd)a 20.4 (14.8) 21.6 (14.9) 17.9 (14.3)
Sex (n,%)
 Male 579 (50.6%) 381 (33.3%) 198 (17.3%)
 Female 565 (49.4%) 382 (33.4%) 183 (16.0%)
Sickle genotype (n,%)
 HbSS and HbSβ0-thalassemia 903 (78.9%) 596 (52.1%) 307 (26.8%)
 HbSC and HbSβ+-thalassemia 241 (21.1%) 167 (14.6%) 74 (6.5%)
 Hydroxyurea therapy at any point during the study period (n,%) 441 (38.5%) 285 (24.9%) 156 (13.6%)
  1. aAge as of the beginning of the observation period